MUC1 and neoplasm: In patients with disease progression, two patients showed loss of tumor MUC1 expression, and one of the patients had MUC-1-specific T cells, suggesting that tumors might evade DC vaccine-induced anti-tumor immunity by down-regulating TAAs.